Kuva Labs Inc. has commenced a tender offer to acquire all outstanding shares of Lisata Therapeutics at $4.00 per share in cash, the companies announced Tuesday, initiating a transaction that could value Lisata at up to $7.00 per share depending on post-close performance benchmarks.
Alongside the base cash consideration, each Lisata shareholder would receive one non-tradeable contingent value right (CVR) entitling the holder to as much as $3.00 per share in two separate contingent cash payments, payable only upon the achievement of specified milestones. The CVRs are non-transferable and will not be listed on any exchange, meaning shareholders bear full illiquidity risk on that portion of the deal consideration.
While Lisata Therapeutics operates outside the traditional food and beverage supply chain, Kuva Labs has drawn attention from F&B industry observers for its portfolio of bioactive ingredient platforms and functional nutrition technologies — areas increasingly intersecting with clinically validated consumer health products. Deals of this structure, pairing a firm upfront price with milestone-contingent earnouts, have become a preferred instrument in functional food and nutraceutical M&A, allowing acquirers to manage valuation risk when target pipelines carry binary outcome uncertainty. For context on how earnout structures are reshaping deal terms across the sector, see our prior coverage of nutraceutical consolidation trends and functional ingredient M&A activity.
The structure reflects a broader pattern in specialty health and nutrition acquisitions, where buyers have grown cautious about paying full premiums upfront for assets whose value hinges on regulatory clearances or clinical data readouts. CVR-linked deals in adjacent health-nutrition categories have historically seen wide variation in payout outcomes, with some rights expiring worthless when milestones slip.
Neither company disclosed the aggregate equity value of the transaction, the expected closing timeline, or the specific milestones that would trigger CVR payments. Regulatory filings with the U.S. Securities and Exchange Commission are expected to provide additional detail on tender conditions, minimum tender thresholds, and termination rights. F&B Industry News will update this report as disclosures become available.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.